Triple-negative Breast Cancer
📧 Sign up to get email alerts when something new happens for Triple-negative Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-02-02Clinical Trial Update: Low-dose Apatinib Combined With Neoadjuvant Chemotherapy in the Treatment of Early Triple Negative Breast Cancer [Phase 2]
Phase 2 trial update evaluating low-dose Apatinib combined with neoadjuvant chemotherapy for early triple-negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-01-12Clinical Trial Update: ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma [Phase 2]
A Phase 2 clinical trial update for ONC201 in recurrent/refractory metastatic breast cancer and advanced endometrial carcinoma has completed…
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: A Trial of Camrelizumab in Combination With Nab-paclitaxel and Famitinib as a First Line Treatment in Patients With Unresectable Locally Advanced or Metastatic Immunomodulatory Triple Negative Breast Cancer(FUTURE-C-PLUS) [Phase 2]
Phase 2 trial evaluating camrelizumab in combination with nab-paclitaxel and famitinib as first-line therapy for unresectable locally advanc…
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT) [Phase 1]
Phase 1 trial update for BN-Brachyury, Entinostat, Adotrastuzumab Emtansine, and M7824 in advanced breast cancer; trial status terminated wi…
-
CLINICAL_TRIALS trial_result · 2022-01-10Clinical Trial Update: Anrotinib in Combination With Capecitabine in Advanced Triple Negative Breast Cancer [Phase 2]
Phase 2 trial update involving anrotinib combined with capecitabine for metastatic triple-negative breast cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-12-28Clinical Trial Update: A Phase II Study of Nivolumab in Combination With Cabozantinib for Metastatic Triple-negative Breast Cancer [Phase 2]
Phase II study of nivolumab plus cabozantinib for metastatic triple-negative breast cancer has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: CISPLATIN + AZD-1775 In Breast Cancer [Phase 2]
Phase 2 trial assessing cisplatin plus AZD-1775 in triple-negative metastatic breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-09Clinical Trial Update: Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With TNBC [Phase 2]
Phase 2 trial of bemcentinib plus pembrolizumab in triple-negative and inflammatory breast cancer was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-02Clinical Trial Update: A Study to Assess the Safety, Tolerability and Antitumor Activity of X4P-001 in Combination With TNBC [Phase 1, Phase 2]
Study investigating safety, tolerability, and antitumor activity of X4P-001 in combination with TNBC in Phase 1/2.
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer [Phase 1, Phase 2]
A clinical trial update reports the completion of a Phase 1/2 study evaluating Talimogene laherparepvec with neoadjuvant chemotherapy for tr…
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: Camrelizumab in Combination With PLD and Losartan in Patients With TNBC Who Have Received ≦ 1 Line of Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating camrelizumab in combination with pegylated liposomal doxorubicin and losartan for patients with triple-neg…
-
CLINICAL_TRIALS trial_result · 2021-10-21Clinical Trial Update: Neoadjuvant Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer [Phase 2]
Phase 2 trial evaluating neoadjuvant camrelizumab combined with chemotherapy in triple negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2021-10-15Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of SG001 in Combination With Nab-Paclitaxel in Patients With Advanced Triple-Negative Breast Cancer (TNBC) [Phase 2]
Phase 2 clinical trial evaluating SG001 with nab-paclitaxel for advanced triple-negative breast cancer; efficacy and safety data not yet ava…
-
CLINICAL_TRIALS trial_result · 2021-10-07Clinical Trial Update: A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC) [Phase 1]
Phase 1 clinical trial update evaluating PF-05212384 in combination with other anti-tumor agents and with cisplatin in expansion arms for tr…
-
CLINICAL_TRIALS trial_result · 2021-09-29Clinical Trial Update: Phase I/II Study of PDR001 in Patients With Advanced Malignancies [Phase 1, Phase 2]
Phase I/II trial update for PDR001 in advanced malignancies completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-09-08Clinical Trial Update: Study Evaluating Efficacy and Safety of SAR566658 Treatment in Patients With CA6 Positive Metastatic Triple Negative Breast Cancer [Phase 2]
Phase 2 trial evaluating SAR566658 in CA6-positive metastatic triple-negative breast cancer has been terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-31Clinical Trial Update: A Study of LY3435151 in Participants With Solid Tumors [Phase 1]
Phase 1 study of LY3435151 in solid tumors, including triple-negative breast cancer, terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-11Clinical Trial Update: Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies [Phase 1, Phase 2]
Phase Ib/II study evaluating MCS110 with PDR001 in advanced malignancies; completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: Neo-Adjuvant Study in Triple Negative Breast Cancer Patients [Phase 2]
Phase 2 neo-adjuvant trial in triple-negative breast cancer completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-23Clinical Trial Update: A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread [Phase 1, Phase 2]
A phase 1/2 study evaluating safety and activity of nivolumab with daratumumab in patients with pancreatic cancer, non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2021-07-21Clinical Trial Update: Oral Etoposide Combined With Anlotinib in Advanced Triple Negative Breast Cancer [Phase 2]
Phase 2 clinical trial investigating oral etoposide in combination with anlotinib for advanced triple negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT [Phase 3]
A phase 3 randomized trial evaluating albumin-bound paclitaxel as neoadjuvant therapy for triple-negative breast cancer is underway.
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer [Phase 4]
Phase 4 trial comparing albumin-bound paclitaxel plus carboplatin to epirubicin and docetaxel for triple-negative breast cancer is currently…
-
CLINICAL_TRIALS trial_result · 2021-07-09Clinical Trial Update: NECTAR Everolimus Plus Cisplatin in Triple (-) Breast Cancer [Phase 2]
Phase 2 trial evaluating everolimus plus cisplatin in triple-negative breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-06-21Clinical Trial Update: Efficacy Study of MCS110 Given With Carboplatin and Gemcitabine in Advanced Triple Negative Breast Cancer (TNBC) [Phase 2]
Phase 2 trial of MCS110 combined with carboplatin and gemcitabine in advanced triple-negative breast cancer with high tumor-associated macro…